Article Details

AstraZeneca asthma drug trial didn't meet endpoint

Retrieved on: 2020-12-22 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca asthma drug trial didn't meet endpoint. View article details on hiswai:

Excerpt

AstraZeneca PLC said Tuesday that the 48-week Phase 3 trial of the potential new medicine tezepelumab--aimed at treating severe asthma--didn't ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up